Indeed, previous studies with a tumor-targeted antibody-LTα fusion protein showed that stimulating TNFR1 in the tumor microenvironment was able to induce MECA-79+ TA-HEV and to eradicate established tumors [283, 284]. The gene discussed is TNFRSF1A; the disease is neoplasm.